Previous works showed high expression of HRAS, KRAS, and NRAS in breast cancer compared with benign breast tissue [48,49]; deletions of HRAS [50,51] but no other mutations in RAS family members; and rare amplifications [52,53]. The gene discussed is KRAS; the disease is breast carcinoma.